Coeptis Therapeutics to Acquire Z Squared in Merger Agreement

Coeptis Therapeutics (NASDAQ:COEP) has entered into a merger agreement with Z Squared, resulting in Z Squared becoming a wholly-owned subsidiary of Coeptis. Under the terms of the agreement, a subsidiary of Coeptis will merge with Z Squared, with the deal expected to close in Q4 2023. The merger is subject to customary closing conditions, including regulatory approvals.